The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / OIG Releases 2017 Work Plan: A Summary

OIG Releases 2017 Work Plan: A Summary

February 14, 2017 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Each fall, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) puts out its Work Plan for the upcoming fiscal year to summarize its initiatives and priorities for new and ongoing work of HSS programs. Below is a summary of the key areas the OIG will focus on in 2017:

You Might Also Like
  • Update & Changes to the OIG Work Plan
  • Design a Compliance Plan for Your Rheumatology Practice
  • Avoid Compliance Risks When Using Billing Companies
Explore This Issue
February 2017
Also By This Author
  • Cigna to Eliminate Consultation Codes

Drug waste of single-use vial drugs: In its review, the OIG will determine the amount of waste for the 20 single-use-vial drugs with the highest amount paid for waste as identified by the “JW” modifier by Medicare and provide specific examples of where a different size vial could significantly reduce waste.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Medicare payments for chronic care management: Payments for chronic care management services (non-face-to-face services provided to Medicare beneficiaries who have multiple chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation or functional decline where the significant chronic conditions are expected to last at least 12 months or until the death of the patient) will be reviewed to verify they met Medicare requirements.

Medicare payments for transitional care management: Also, the OIG will determine whether payments for transitional care management services (services provided to a patient whose medical and/or psychosocial problems require moderate- or high-complexity medical decision making during transitions in care from an inpatient hospital setting, partial hospital, observation status in a hospital or skilled nursing facility/nursing facility to the patient’s community setting) met Medicare requirements.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Prolonged services & the reasonableness of the services: The OIG will review Medicare claims for additional care provided to a beneficiary after an evaluation and management service was performed to determine whether payments to the physician were reasonable and met requirements.

Monitoring Medicare payments for clinical diagnostic laboratory tests—mandatory review: Medicare payments for clinical diagnostic laboratory tests performed in 2016 will be analyzed, and they will monitor the CMS’s establishment of the new Medicare payment system for the top 25 diagnostic tests.

Comparison of average sales prices to average manufacturer prices—mandatory review: The OIG will review Medicare Part B drug prices by comparing ASPs to AMPs and identify drug prices that exceed a designated threshold for reimbursements.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Use of electronic health records to support care coordination through ACOs: The OIG will review the extent to which providers participating in ACOs in the Medicare Shared Savings Program (MSSP) use EHRs to exchange health information to achieve their care coordination goals. They will assess providers’ use of EHRs to identify best practices and possible challenges to the exchange and use of health data, such as degree of interoperability, financial barriers or information blocking.

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: 2017, CMS, Department of Health and Human Services, diagnostic care, Drugs, federal, government, Medicaid, Medicare, Medication, Office of Inspector General, patient care, Practice Management, rheumatologist, rheumatology, work planIssue: February 2017

You Might Also Like:
  • Update & Changes to the OIG Work Plan
  • Design a Compliance Plan for Your Rheumatology Practice
  • Avoid Compliance Risks When Using Billing Companies
  • U.S. to Raise Payments to Insurers for Medicare Advantage 2017 Plans

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)